Schedule 13G Filing for Aethlon Medical, Inc.

This Schedule 13G filing, submitted by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, discloses their beneficial ownership of 7.7% of Aethlon Medical, Inc.'s common stock. The filing details the ownership structure following the execution of a Securities Purchase Agreement on September 4, 2025, which includes shares issued and warrants exercisable into additional shares. The Reporting Persons collectively hold 576,603 shares, with shared voting and dispositive power over these shares. The filing also includes a Joint Filing Agreement, confirming that the statement is filed on behalf of all Reporting Persons and that subsequent amendments may be filed jointly without additional agreements.